Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...

Pfizer has concluded a global licensing agreement with 3SBio, excluding China, which grants it exclusive rights for the 3SBio’s SSGJ-707.

Ex-Pfizer Execs Backed Its Leadership. ... The ex-Pfizer executives, Ian Read and Frank D'Amelio, said they didn't want to get involved with Starboard's efforts to seek change.

Pfizer Inc. today announced changes to its executive leadership team to further advance its aspirations to discover and develop new medicines and vaccines, with an emphasis on oncology. Under his ...

Pfizer is reorganizing its research leadership team, assigning additional duties to Chief Scientific Officer Mikael Dolsten, M.D., PhD., while bidding farewell to Chief Development Officer William ...

Roy Ronen, Data4Cure's CTO, added, "It is immensely gratifying to see Data4Cure's platform being applied to support a broad range of research areas as part of a long-running collaboration with Pfizer.

Pfizer offers a variety of mentoring opportunities through its program, 'Growing STEM Futures.' Sharing data, explaining the science and listening to people's concerns can help address vaccine ...

The leadership playbook you've relied on for so many years is now being rewritten (literally and philosophically) by artificial intelligence, and younger employees are coming to your team ...